` AUGX (Augmedix Inc) vs S&P 500 Comparison - Alpha Spread

AUGX
vs
S&P 500

Over the past 12 months, AUGX has significantly outperformed S&P 500, delivering a return of 192% compared to the S&P 500's 9% growth.

Stocks Performance
AUGX vs S&P 500

Loading
AUGX
S&P 500
Add Stock
www.alphaspread.com

Performance Gap
AUGX vs S&P 500

Loading
AUGX
S&P 500
Difference
www.alphaspread.com

Performance By Year
AUGX vs S&P 500

Loading
AUGX
S&P 500
Add Stock

Competitors Performance
Augmedix Inc vs Peers

S&P 500
AUGX
VEEV
PME
DOCS
2413
Add Stock

Augmedix Inc
Glance View

Market Cap
115.3m USD
Industry
Health Care

Augmedix, Inc. engages in the development of software that converts natural clinician-patient conversations into medical documentation. The company is headquartered in San Francisco, California and currently employs 706 full-time employees. The company went IPO on 2021-03-04. The Company’s Ambient Automation Platform converts the natural conversation between physicians and patients into timely and comprehensive medical notes and provides a suite of related services. The medical note is generated using Augmedix’s proprietary platform, which incorporates structured data models, automatic speech recognition and natural language processing and is overseen by trained medical documentation specialists (MDS). Augmedix provides service from approximately nine MDS operations centers across four countries: the United States, Bangladesh, India and Sri Lanka.

AUGX Intrinsic Value
2.51 USD
Undervaluation 6%
Intrinsic Value
Price
Back to Top